HomePharmaceutical Neulasta Market

Neulasta Market Size, Share & Trends Analysis Report By Drug Type (Branded, Biosimilars), Market Share (Branded, Biosimilars), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Route of Administration (Pre-filled Syringes, On-body Injectors (OBI)), By End User (Cancer Treatment Centers, Hospitals, Homecare Settings) and By Region (North America, Europe, Asia-Pacific, Latin America, The Middle East and Africa) Forecasts, 2025-2030

Starting From
USD 4500

Buy Now

Report Benefits

Develop business strategies by understanding the trends shaping and driving the Market.

Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Market in the future.

Formulate effective sales and marketing strategies by understanding the competitive landscape and by analysing the company share of market leaders.

Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.

Track sales in the global and country-specific Market.

Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Executive Summary
1. Introduction
Market Introduction
1. Market Definition
2. Scope of the Study
3. Market Structure
Research Methodology
1. Primary Research
2. Research Methodology
3. Assumptions & Exclusions
4. Secondary Data Sources
Market Factor Analysis
1. Value Chain Analysis: Neulasta Market
2. Porters Five Forces Analysis
  1. Bargaining Power of Suppliers
  2. Bargaining Power of Buyers
  3. Threat of Substitution
  4. Threat of New Entrants
  5. Competitive Rivalry
Market Dynamics
1. Drivers
2. Restraints
3. Opportunities
Recent Trends Analysis
Impact of COVID-19 on Neulasta Market
1. Pre and Post Covid -19 Market Scenario Analysis
2. Market Recovery Timeline and Challenge
3. Measures Taken by Top Players
Regulatory Landscape
Neulasta Market, By Drug Type
1. Introduction
  1. Market Size and Forecast, By Drug Type
2. Branded
  1. Market Size and Forecast, By Region
3. Biosimilars
  1. Market Size and Forecast, By Region
Neulasta Market, Market Share
1. Introduction
  1. Market Size and Forecast, Market Share
2. Branded
  1. Market Size and Forecast, By Region
3. Biosimilars
  1. Market Size and Forecast, By Region
Neulasta Market, By Distribution Channel
1. Introduction
  1. Market Size and Forecast, By Distribution Channel
2. Hospital Pharmacies
  1. Market Size and Forecast, By Region
3. Retail Pharmacies
  1. Market Size and Forecast, By Region
4. Online Pharmacies
  1. Market Size and Forecast, By Region
Neulasta Market, By Route of Administration
1. Introduction
  1. Market Size and Forecast, By Route of Administration
2. Pre-filled Syringes
  1. Market Size and Forecast, By Region
3. On-body Injectors (OBI)
  1. Market Size and Forecast, By Region
Neulasta Market, By End User
1. Introduction
  1. Market Size and Forecast, By End User
2. Cancer Treatment Centers
  1. Market Size and Forecast, By Region
3. Hospitals
  1. Market Size and Forecast, By Region
4. Homecare Settings
  1. Market Size and Forecast, By Region
Regional Overview
1. Introduction
  1. Market Size and Forecast
2. North America
  1. Market Size and Forecast
    1. By Drug Type
      1. Branded
      2. Biosimilars
    2. Market Share
      1. Branded
      2. Biosimilars
    3. By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    4. By Route of Administration
      1. Pre-filled Syringes
      2. On-body Injectors (OBI)
    5. By End User
      1. Cancer Treatment Centers
      2. Hospitals
      3. Homecare Settings
  2. U.S.
    1. By Drug Type
      1. Branded
      2. Biosimilars
    2. Market Share
      1. Branded
      2. Biosimilars
    3. By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    4. By Route of Administration
      1. Pre-filled Syringes
      2. On-body Injectors (OBI)
    5. By End User
      1. Cancer Treatment Centers
      2. Hospitals
      3. Homecare Settings
  3. Canada
3. Europe
  1. Market Size and Forecast
    1. By Drug Type
      1. Branded
      2. Biosimilars
    2. Market Share
      1. Branded
      2. Biosimilars
    3. By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    4. By Route of Administration
      1. Pre-filled Syringes
      2. On-body Injectors (OBI)
    5. By End User
      1. Cancer Treatment Centers
      2. Hospitals
      3. Homecare Settings
  2. U.K.
    1. By Drug Type
      1. Branded
      2. Biosimilars
    2. Market Share
      1. Branded
      2. Biosimilars
    3. By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    4. By Route of Administration
      1. Pre-filled Syringes
      2. On-body Injectors (OBI)
    5. By End User
      1. Cancer Treatment Centers
      2. Hospitals
      3. Homecare Settings
  3. Germany
  4. France
  5. Spain
  6. Italy
  7. Russia
  8. Nordic
  9. Benelux
  10. Rest of Europe
4. APAC
  1. Market Size and Forecast
    1. By Drug Type
      1. Branded
      2. Biosimilars
    2. Market Share
      1. Branded
      2. Biosimilars
    3. By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    4. By Route of Administration
      1. Pre-filled Syringes
      2. On-body Injectors (OBI)
    5. By End User
      1. Cancer Treatment Centers
      2. Hospitals
      3. Homecare Settings
  2. China
    1. By Drug Type
      1. Branded
      2. Biosimilars
    2. Market Share
      1. Branded
      2. Biosimilars
    3. By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    4. By Route of Administration
      1. Pre-filled Syringes
      2. On-body Injectors (OBI)
    5. By End User
      1. Cancer Treatment Centers
      2. Hospitals
      3. Homecare Settings
  3. Korea
  4. Japan
  5. India
  6. Australia
  7. Singapore
  8. Taiwan
  9. South East Asia
  10. Rest of Asia-Pacific
5. Middle East and Africa
  1. Market Size and Forecast
    1. By Drug Type
      1. Branded
      2. Biosimilars
    2. Market Share
      1. Branded
      2. Biosimilars
    3. By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    4. By Route of Administration
      1. Pre-filled Syringes
      2. On-body Injectors (OBI)
    5. By End User
      1. Cancer Treatment Centers
      2. Hospitals
      3. Homecare Settings
  2. UAE
    1. By Drug Type
      1. Branded
      2. Biosimilars
    2. Market Share
      1. Branded
      2. Biosimilars
    3. By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    4. By Route of Administration
      1. Pre-filled Syringes
      2. On-body Injectors (OBI)
    5. By End User
      1. Cancer Treatment Centers
      2. Hospitals
      3. Homecare Settings
  3. Turky
  4. Saudi Arabia
  5. South Africa
  6. Egypt
  7. Nigeria
  8. Rest of MEA
6. LATAM
  1. Market Size and Forecast
    1. By Drug Type
      1. Branded
      2. Biosimilars
    2. Market Share
      1. Branded
      2. Biosimilars
    3. By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    4. By Route of Administration
      1. Pre-filled Syringes
      2. On-body Injectors (OBI)
    5. By End User
      1. Cancer Treatment Centers
      2. Hospitals
      3. Homecare Settings
  2. Brazil
    1. By Drug Type
      1. Branded
      2. Biosimilars
    2. Market Share
      1. Branded
      2. Biosimilars
    3. By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    4. By Route of Administration
      1. Pre-filled Syringes
      2. On-body Injectors (OBI)
    5. By End User
      1. Cancer Treatment Centers
      2. Hospitals
      3. Homecare Settings
  3. Mexico
  4. Argentina
  5. Chile
  6. Colombia
  7. Rest of LATAM
Competitive Landscape, 2024
1. Introduction
2. Neulasta Market Share Analysis, 2024 (%)
  1. Market Share Analysis, 2024
  2. Competition Ranking, 2024
  3. Key Developments & Growth Strategies
    1. Merger & Acquisition
    2. Product Launch
    3. Expansion
  4. Consolidated SWOT Analysis of Key Players
Company Profile
1. Mylan/Biocon
  1. Business Overview
  2. Financial Data
  3. Key Product Categories
  4. Recent Developments
2. Sandoz
3. Pfizer
4. Teva
5. Apotex
6. Accord
7. Fresenius Kabi

Report Benefits

Table of Contents